SecurityRAS / RAIT Financial Trust (749227609)
Int. CEO, Int. Pres. & GCReyle John J.
IndustryReal Estate Investment Trusts
Institutional Owners82
Institutional Shares47,851,926 - 51.69%
Common Stock Shares Outstanding92,576,726 shares (as of 2018-03-31)
Institutional Value$ 43,062,000 USD
Related RAS.PRA / RAIT Financial Trust
RAS.PRB / RAIT Financial Trust
RTFA / RAIT Financial Trust
RASF / RAIT Financial Trust
RFTA / RAIT Financial Trust
RAS.PRC / RAIT Financial Trust
RFT / RAIT Financial Trust
RASFO / RAIT Financial Trust 8.375% Series B Cumulative Redeemable Preferred Shares
RASFN / RAIT Financial Trust 8.875% Series C Cumulative Redeemable Preferred Shares

Institutional Stock Ownership and Shareholders

RAS / RAIT Financial Trust Institutional Ownership

RAIT Financial Trust (NYSE:RAS) has 82 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 47,851,926 shares. Largest shareholders include Vanguard Specialized Funds, Tricadia Capital Management, LLC, BlackRock Inc., Highland Capital Management Lp, BlackRock Fund Advisors, Renaissance Technologies LLC, BlackRock Institutional Trust Company, N.A., Vanguard Group Inc, State Street Corp, and Allianz Asset Management AG.
RAIT Financial Trust (NYSE:RAS) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/ras"><img src="https://images.fintel.io/us-ras-so.png" alt="RAS / RAIT Financial Trust Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-04-27 13F-HR LOS ANGELES CAPITAL MANAGEMENT & EQUITY RESEARCH INC 135,480 135,480 0.00 51 22 -56.86
2018-05-15 13F-HR STATE STREET CORP 2,166,274 1,533,401 -29.21 813 246 -69.74
2017-02-13 SC 13G/A VANGUARD SPECIALIZED FUNDS 6,595,820 7,030,743 6.59
2018-05-15 13F-HR Bank of New York Mellon Corp 595,154 599,069 0.66 223 97 -56.50
2018-05-14 13F-HR Royce & Associates LLC 1 1 0.00 0 0
2017-02-10 13F-HR BlackRock Investment Management, LLC 367,207 367,207 0.00 1,241 1,234 -0.56
2018-05-11 13F-HR Private Ocean, LLC 10,000 10,000 0.00 4 1 -75.00
2018-05-15 13F-HR BARCLAYS PLC 23,164 25,247 8.99 8 4 -50.00
2018-05-15 13F-HR RBF Capital, LLC 21,000 0 -100.00 8 0 -100.00
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 5,000 5,000 0.00 2 1 -50.00
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 51,456 0 -100.00 19 0 -100.00
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 1,183,475 89,096 -92.47 444 14 -96.85
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 75,600 75,600 0.00 28 12 -57.14
2018-05-14 13F-HR UNITED SERVICES AUTOMOBILE ASSOCIATION 12,466 2
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 47,100 11,900 -74.73 18 2 -88.89
2018-05-04 13F-HR LMR Partners LLP 13,764 13,764 0.00 5 5 0.00
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 17,555 718 -95.91 6 0 -100.00
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 1,409,016 0 -100.00 528 0 -100.00
2018-05-03 13F-HR SG Americas Securities, LLC 72,991 137,289 88.09 27 22 -18.52
2018-05-15 13F-HR Voya Investment Management LLC 65,583 65,583 0.00 25 11 -56.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 261,178 0 -100.00 98 0 -100.00
2018-05-08 13F-HR Advisornet Financial, Inc 97,557 97,557 0.00 37 16 -56.76
2017-05-01 13F-HR Spot Trading L.L.C Put 21,000 67
2018-05-09 13F-HR NORTHERN TRUST CORP 1,080,453 1,069,146 -1.05 405 173 -57.28
2018-05-15 13F-HR LPL Financial LLC 13,759 13,876 0.85 5 2 -60.00
2018-05-09 13F-HR Private Advisor Group, LLC 0 14,500 0 2
2018-05-07 13F-HR Tricadia Capital Management, LLC 6,656,391 6,656,391 0.00 2,529 1,075 -57.49
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 4,187 9,187 119.42 2 1 -50.00
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 229,832 135,302 -41.13 86 22 -74.42
2018-05-14 13F-HR DIAM Co., Ltd. 10,357 0 -100.00 4 0 -100.00
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 218,621 28,906 -86.78 82 5 -93.90
2018-04-26 13F-HR SIMPLEX TRADING, LLC 0 1,100 0 0
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 39,635 27,254 -31.24 14,863 4,402 -70.38
2018-05-11 13F-HR CITADEL ADVISORS LLC 28,906 5
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 61,866 58,709 -5.10 23 9 -60.87
2018-05-14 13F-HR Renaissance Technologies LLC 3,579,200 3,209,100 -10.34 1,342 518 -61.40
2018-05-15 13F-HR TUDOR INVESTMENT CORP ET AL 66,662 66,662 0.00 25 11 -56.00
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 176,099 159,900 -9.20 67 26 -61.19
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 62,500 0 -100.00 23 0 -100.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 438,213 327,693 -25.22 163 51 -68.71
2018-05-14 13F-HR Virtu Financial LLC 73,469 119,692 62.91 28 19 -32.14
2018-05-02 13F-HR RHUMBLINE ADVISERS 91,422 91,422 0.00 34 15 -55.88
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 27,085 0 -100.00 10 0 -100.00
2018-05-10 13F-HR Myda Advisors Llc 90,000 0 -100.00 34 0 -100.00
2018-05-15 13F-HR VANGUARD GROUP INC 1,421,181 1,662,086 16.95 533 269 -49.53
2018-05-14 13F-HR Pinnacle Holdings, LLC 54,550 54,550 0.00 20,456 8,810 -56.93
2018-04-18 13F-HR Creative Planning 625,500 425,000 -32.05 235 69 -70.64
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 7,053 7,053 0.00 3 1 -66.67
2017-02-10 13F-HR BlackRock Group LTD 21,929 21,929 0.00 74 73 -1.35
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 28,095 27,360 -2.62 11 4 -63.64
2018-05-15 13F-HR EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC 37,541 22,441 -40.22 14 4 -71.43
2018-04-23 13F-HR Financial Architects, Inc 5 2 -60.00
2018-04-25 13F-HR RMR Advisors LLC 178,419 178,419 0.00 67 29 -56.72
2017-02-10 13F-HR BlackRock Fund Advisors 4,543,902 4,457,491 -1.90 15,358 14,977 -2.48
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 297,167 295,627 -0.52 111 48 -56.76
2018-05-10 13F-HR JP Morgan Chase & Co 38,939 21,470 -44.86 14 3 -78.57
2018-05-15 13F-HR BLAIR WILLIAM & CO/IL 68,000 68,000 0.00 26 11 -57.69
2018-05-15 13F-HR UBS Group AG 202,778 150,300 -25.88 76 24 -68.42
2017-02-10 13F-HR BlackRock Advisors LLC 35,941 35,941 0.00 121 121 0.00
2018-05-17 13F-HR Legal & General Group Plc 24,922 13,621 -45.35 9 2 -77.78
2018-05-23 13F-HR/A Allianz Asset Management AG 1,486,820 1,486,820 0.00 558 240 -56.99
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 12,684 0 -100.00 5 0 -100.00
2018-05-04 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 42,616 42,616 0.00 16 7 -56.25
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 189,938 158,403 -16.60 72 25 -65.28
2018-04-04 13F-HR CENTRAL TRUST Co 200 0 -100.00 0 0
2018-04-09 13F-HR Founders Capital Management 14,000 22,000 57.14 5 4 -20.00
2018-05-09 13F-HR BlackRock Inc. 5,440,986 5,419,693 -0.39 2,041 874 -57.18
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 2,396,030 2,393,906 -0.09 8,099 8,044 -0.68
2018-05-11 13F-HR CITIGROUP INC 18,656 26,454 41.80 7 4 -42.86
2018-05-11 13F-HR SEI INVESTMENTS CO 88 123 39.77 0 0
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 20,533 10,333 -49.68 8 2 -75.00
2018-05-11 13F-HR Parisi Gray Wealth Management 3,200 3,200 0.00 1 1 0.00
2018-05-15 13F-HR Invesco Ltd. 413,931 1,009,729 143.94 155 163 5.16
2018-05-09 13F-HR IFP Advisors, Inc 333 333 0.00 0 0
2018-04-20 13F-HR STRS OHIO 28,500 28,500 0.00 10 4 -60.00
2018-05-14 13F-HR TEACHERS ADVISORS INC 113,214 0 -100.00 42 0 -100.00
2018-05-14 13F-HR Shell Asset Management Co 152,905 0 -100.00 57 0 -100.00
2018-05-01 13F-HR WEDBUSH SECURITIES INC 0 16,917 0 3
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 17,308 11,679 -32.52 6 2 -66.67
2018-05-14 13F-HR ProShare Advisors LLC 13,635 11,739 -13.91 5 2 -60.00
2018-05-15 13F-HR Cubist Systematic Strategies, LLC 126,226 125,370 -0.68 47 20 -57.45
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 155,233 155,233 0.00 58 25 -56.90
2017-01-13 13F-HR MetLife Securities, Inc 201 0 -100.00 1 0 -100.00
2018-05-15 13F-HR Atlantic Trust, LLC 295 0 -100.00 0 0
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 62,793 62,004 -1.26 23 10 -56.52
2018-05-15 13F-HR HIGHLAND CAPITAL MANAGEMENT LP 4,691,811 4,691,811 0.00 1,759 758 -56.91
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 14,056 0 -100.00 5 0 -100.00
2018-05-22 13F-HR AMALGAMATED BANK 12,290 11,305 -8.01 5 2 -60.00
2018-05-14 13F-HR MORGAN STANLEY 329,236 266,083 -19.18 124 43 -65.32
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 792,734 768,580 -3.05 297 124 -58.25
2017-05-01 13F-HR Spot Trading L.L.C 8,092 26
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 49,598 49,137 -0.93 19 8 -57.89
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 57,800 90,400 56.40 22 15 -31.82
2018-05-09 13F-HR Cetera Advisors LLC 563,924 456,124 -19.12 185 46 -75.14
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 13,591 0 -100.00 5 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 11,900 2
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 903,409 798,090 -11.66 339 129 -61.95
2018-05-15 13F-HR CREDIT SUISSE AG/ 26,642 34,232 28.49 10 5 -50.00
2018-05-15 13F-HR Point72 Asia (Hong Kong) Ltd 20,050 17,606 -12.19 8 3 -62.50
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 9,477 8,059 -14.96 4 1 -75.00
2018-04-26 13F-HR CWM, LLC 100 100 0.00 0 0
2018-05-01 13F-HR SUMMIT SECURITIES GROUP, LLC 10,000 2

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Related News Stories

How To Retire Today: Dividends

2018-06-11 seekingalpha
This is a tricky subject because there are very important factors to consider on each side. (36-0)

12 Retirement Rules You Need In 2018

2018-04-24 seekingalpha
The first step toward a great retirement is making saving for retirement a priority. There are annual limits on the amount individuals can contribute to their retirement accounts. (131-0)

How To Retire At 65 With Only Half A Million

2018-04-23 seekingalpha
How to retire is a pressing issue we must all face at some point. Countless readers have turned to Seeking Alpha to handle retirement challenges. (52-0)

Landmark Infrastructure Partners LP: These 7% Floating-To-Fixed Preferred Units Started Trading On The Nasdaq

2018-04-20 seekingalpha
In this article, we want to shed light on a new Preferred Units issued by Landmark Infrastructure Partners LP (LMRK). (45-0)

Dead Dividend Stocks Are Just Stocks To Sell

2018-04-13 seekingalpha
Simon Property Group (SPG) is still a buy. They have been a buy since summer of 2017. SPG is the best of the mall REIT operators. They have the best net operating margins on their properties and they have the best scale on their overhead expenses. Consequently, they are able to extract more value out of each property than any of their peers. On average, SPG's portfolio is very high quality. It is not quite as good as the portfolio for Taubman Centers (TCO) measured by sales per square foot, but they still have the best margins. (45-2)

CUSIP: 749227609